Drug Approvals

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference that will be held on 8–9 October 2026 in Kolkata. The...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise,  announced the launch of Hospital...

CDSCO Issues Final Guidance for Medical Device Software Under MDR 2017

The Central Drugs Standard Control Organisation (CDSCO), functioning under the Directorate General of Health Services, Ministry of Health...

Lupin Secures U.S. FDA Tentative Approval for Enzalutamide Tablets

Lupin Limited (Lupin) the Mumbai, India based global pharma major earlier this week had announced that the company has received tentative approval from the...

Mayo Clinic Finds Common Surgical Drug Could Reduce Risk of Liver Failure

Researchers at Mayo Clinic and Michigan State University have uncovered a potentially life-saving application for tranexamic acid, a widely used clot-preserving medication, in the context of...

New Hope for Thyroid Eye Disease Treatment as FDA Approves Lumvoa

Waltham-based Viridian Therapeutics (Nasdaq: VRDN) has secured U.S. Food and Drug Administration clearance for Lumvoa™ (veligrotug-vvze), marking the company's debut as a commercial-stage biotech and...

FDA Approves AbbVie’s SKYRIZI®️ for Pediatric Patients with Psoriatic Disease

AbbVie  announced that the U.S. Food and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for children aged six and older living with moderate-to-severe plaque...

Trodelvy Approved in Europe for Hard-to-Treat Breast Cancer Patients

The European Commission has granted marketing authorization for Trodelvy® (sacituzumabgovitecan) as an initial treatment for adults with unresectable or metastatic triple-negative breast cancer (mTNBC) who are ineligible...

Maiva Pharma launches brand-new, 22-acre sterile injectables plant in Tamil Nadu

Maiva Pharma Private Limited, a leading US FDA-approved sterile injectables manufacturer, has officially inaugurated its brand-new manufacturing plant. Spanning a sprawling 22-acre campus in Shoolagiri, Tamil Nadu, the...